Recalls & Warnings April 25, 2020 Injectable Curcumin, CBD Are Not Safe, Warns FDA On April 9, 2020, the FDA issued a warning letter to BIOTA Biosciences LLC following a review of the company's website, which found statements made about some of the company's, products, including Canabidiol (CBD) Complex, Cannabidiol+Curcumin, and Curcumin Complex to be
Consult your doctor if problems persist
Pinch a skinfold at the injection site (abdomen preferred, at least 2 inches from navel) [6]
Possible causes: dead space accumulation (discussed above), inaccurate water volume at reconstitution (more water means more dilute, means more volume per dose, means fewer doses from the same amount of peptide), or air in the vial displacing solution
For low doses (0.25-0.5mg at 2.5 mg/mL), a 0.3 mL (30 unit) syringe provides larger graduation marks that are easier to read than a 1 mL (100 unit) syringe